About Accrete Pharma
Accrete Pharma is a company based in Hyderabad (India) founded in 2007 by DN Mohan Reddy. It operates as a B2B. The company has 52 employees as of March 31, 2023. Accrete Pharma offers products and services including Pazopanib Intermediates, Ibrutinib Intermediates, Imatinib Intermediates, and Lenalidomide Intermediates. Accrete Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 52 as on 31 Mar, 2023
- Founders DN Mohan Reddy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Accrete Pharmaceuticals Private Limited
- Date of Incorporation 23 Jul, 2004
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$3.51 M (USD)2.52as on Mar 31, 2023
-
Net Profit
$750.8 K (USD)60.25as on Mar 31, 2023
-
EBITDA
$1.45 M (USD)24.85as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
52
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accrete Pharma
Accrete Pharma offers a comprehensive portfolio of products and services, including Pazopanib Intermediates, Ibrutinib Intermediates, Imatinib Intermediates, and Lenalidomide Intermediates.
Intermediates used for manufacturing anti-cancer drug Pazopanib.
Intermediates for producing anti-cancer drug Ibrutinib.
Intermediates for anti-cancer drug Imatinib production.
Intermediates for anti-cancer drug Lenalidomide.
Funding Insights of Accrete Pharma
Detailed funding history for Accrete Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accrete Pharma
Investment portfolio details for Accrete Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accrete Pharma
Detailed financials for Accrete Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accrete Pharma Comparisons
Peer comparison for Accrete Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accrete Pharma
Accrete Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Accrete Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accrete Pharma
Complete news archive for Accrete Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accrete Pharma
Accrete Pharma was founded in 2007.
Accrete Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Accrete Pharma is 52.
Annual revenue of Accrete Pharma is $3.51M as on Mar 31, 2023.
Accrete Pharmaceuticals Private Limited is an ISO-certified company that produces bulk drug intermediates, primarily for anti-cancer products. Based in Hyderabad, India, they focus on quality manufacturing, proper documentation, and customer satisfaction in the pharmaceutical industry. They operate a cGMP-compliant facility and prioritize advanced technologies for product development, supplying intermediates to other pharma companies while maintaining environmental standards.
Accrete Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Accrete Pharma offers Pazopanib Intermediates, Ibrutinib Intermediates, Imatinib Intermediates, and Lenalidomide Intermediates.